AP-002

· Altum Pharmaceuticals INC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP-002, covering 2019-10-31 to 2019-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of AP-002 in Patients With Solid Tumors [Phase 1, Phase 2]